P2X7 receptor stimulation in primary cultures of rat spinal microglia induces downregulation of the activity for glutamate transport

GLIA

Volumn 56, Issue 5, 2008, Pages 528-538

  Morioka, Norimitsu ^a   Abdin, Md Joynal ^a   Kitayama, Tomoya ^a   Morita, Katsuya ^a   Nakata, Yoshihiro ^a   Dohi, Toshihiro ^a,b  

^a HIROSHIMA UNIVERSITY   (Japan)

^b HIROSHIMA UNIVERSITY   (Japan)

Author keywords

ATP; ERK; Glutamate transporters; Reactive oxygen species; Spinal cord

Indexed keywords

ADENOSINE TRIPHOSPHATE DERIVATIVE; ANTIOXIDANT; BRILLIANT BLUE; CALCIUM ION; EXCITATORY AMINO ACID TRANSPORTER; GLUTAMIC ACID; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; PURINERGIC P2X7 RECEPTOR; PURINERGIC RECEPTOR BLOCKING AGENT; PURINERGIC RECEPTOR STIMULATING AGENT; SODIUM ION; VESICULAR GLUTAMATE TRANSPORTER 1; 3' O (4 BENZOYL)BENZOYLADENOSINE 5' TRIPHOSPHATE; 3'-O-(4-BENZOYL)BENZOYLADENOSINE 5'-TRIPHOSPHATE; ADENOSINE TRIPHOSPHATE; ANTITHROMBOCYTIC AGENT; CALCIUM; DRUG DERIVATIVE; ENZYME INHIBITOR; EXCITATORY AMINO ACID TRANSPORTER 1; EXCITATORY AMINO ACID TRANSPORTER 2; PURINERGIC P2 RECEPTOR; SLC1A3 PROTEIN, RAT; SODIUM;

ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; CELL COMMUNICATION; CELL STIMULATION; CONTROLLED STUDY; ENZYME ACTIVATION; MICROGLIA; NEWBORN; NONHUMAN; OXIDATION; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN FUNCTION; RAT; RECEPTOR BLOCKING; RECEPTOR DOWN REGULATION; REGULATORY MECHANISM; SPINAL CORD NERVE CELL; ANIMAL; BIOTINYLATION; CELL CULTURE; CYTOLOGY; DOSE RESPONSE; DOWN REGULATION; DRUG EFFECT; DRUG INTERACTION; GENETICS; METABOLISM; METHODOLOGY; PHYSIOLOGY; SPINAL CORD; TIME;

ADENOSINE TRIPHOSPHATE; ANIMALS; ANIMALS, NEWBORN; BIOTINYLATION; CALCIUM; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; DRUG INTERACTIONS; ENZYME INHIBITORS; EXCITATORY AMINO ACID TRANSPORTER 1; EXCITATORY AMINO ACID TRANSPORTER 2; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GLUTAMIC ACID; MICROGLIA; PLATELET AGGREGATION INHIBITORS; RATS; RECEPTORS, PURINERGIC P2; SODIUM; SPINAL CORD; TIME FACTORS;

EID: 44949230478     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.20634     Document Type: Article

References (42)

1. 2+ influx. Biochem J 374:51-61.
2. Arriza JL, Eliasof S, Kavanaugh MP, Amara SG. 1997. Excitatory amino acid transporter 5, a retinal glutamate transporter coupled to a chloride conductance. Proc Natl Acad Sci USA 94:4155-4160.
3. Arriza JL, Fairman WA, Wadiche JI, Murdoch GH, Kavanaugh MP, Amara SG. 1994. Functional comparisons of three glutamate transporter subtypes cloned from human motor cortex. J Neurosci 14:5559-5569.
4. Beckman ML, Bernstein EM, Quick MW. 1998. Protein kinase C regulates the interaction between a GABA transporter and syntaxin 1A. J Neurosci 18:6103-6112.
5. Beschorner R, Dietz K, Schauer N, Mittelbronn M, Schluesener HJ, Trautmann K, Meyermann R, Simon P 2007. Expression of EAAT1 reflects a possible neuroprotective function of reactive astrocytes and activated microglia following human traumatic brain injury. Histol Histopathol 22:515-526.
6. 7 receptors activate protein kinase D, p42/p44 mitogen-activated protein kinase (MAPK) downstream of protein kinase C. Biochem. J 366:745-755.
7. Conradt M, Stoffel W. 1997. Inhibition of the high-affinity brain glutamate transporter GLAST-1 via direct phosphorylation. J Neurochem 68:1244-1251.
8. Duan S, Anderson CM, Stein BA, Swanson RA. 1999. Glutamate induces rapid upregulation of astrocytes glutamate transport and cell-surface expression of GLAST. J Neurosci 19:10193-10200.
9. Dunlop J, Beal McIlvain H, She Y, Howland DS. 2003. Impaired spinal cord glutamate transport capacity and reduced sensitivity to riluzole in a transgenic superoxide dismutase mutant rat model of amyotrophic lateral sclerosis. J Neurosci 23:1688-1696.
10. Fairman WA, Vandenberg RJ, Arriza JL, Kavanaugh MP, Amara SG. 1995. An excitatory amino-acid transporter with properties of a ligand-gated chloride channel. Nature 375:599-603.
11. Fine SM, Angel RA, Perry SW, Epstein LG, Rothstein JD, Dewhurst S, Gelbard HA. 1996. Tumor necrosis factor a inhibits glutamate uptake by primary human astrocytes. Implications for pathogenesis of HIV dementia. J Biol Chem 271:15303-15306.
12. Guillet BA, Velly LJ, Canolle B, Masmejean FM, Nieoullon AL, Pisano P. 2005. Differential regulation by protein kinases of activity and cell surface expression of glutamate transporters in neuron-enriched cultures. Neurochem Int 46:337-346.
13. Hayashi T, Umemori H, Mishina M, Yamamoto T. 1999. The AMPA receptor interacts with and signals through the protein tyrosine kinase Lyn. Nature 397:72-76.
14. Hide I, Tanaka M, Inoue A, Nakajima K, Kohsaka S, Inoue K, Nakata Y. 2000. Extracellular ATP triggers tumor necrosis factor-α release from rat microglia. J Neurochem 75:965-972.
15. Hsu HY, Wen MH. 2002. Lipopolysaccharide-mediated reactive oxygen species and signal transduction in the regulation of interleukin-1 gene expression. J Biol Chem 277:22131-22139.
16. Jones LL, Tuszynski MH. 2002. Spinal cord injury elicits expression of keratin sulfate proteoglycans by macrophages, reactive microglia, and oligodendrocyte progenitors. J Neurosci 22:4611-4624.
17. Kalandadze A, Wu Y, Robinson MB. 2002. Protein kinase C activation decrease cell surface expression of the GLT-1 subtype of glutamate transporter. J Biol Chem 277:45741-45750.
18. Kanai Y, Hediger MA. 1992. Primary structure and functional characterization of a high-affinity glutamate transporter. Nature 360:467-471.
19. Liu D, Xu GY, Pan E, McAdoo DJ. 1999. Neurotoxicity of glutamate at the concentration released upon spinal cord injury. Neuroscience 93:1383-1389.
20. López-Redondo F, Nakajima K, Honda S, Kohsaka S. 2000. Glutamate transporter GLT-1 is highly expressed in activated microglia following facial nerve axotomy. Mol Brain Res 76:429-435.
21. Morón JA, Zakharova I, Ferrer JV, Merrill GA, Hope B, Lafer EM, Lin ZC, Wang JB, Javitch JA, Galli A, Shippenberg TS. 2003. Mitogen-activated protein kinase regulates dopamine transporter surface expression and dopamine transporter capacity. J Neurosci 23:8480-8488.
22. 2+ entry in rabbit osteoclasts. J Biol Chem 276:39107-39114.
23. Nasu-Tada K, Koizumi S, Inoue K. 2005. Involvement of β1 integrin in microglial chemotaxis and proliferation on fibronectin: Different regulations by ADP through PKA. Glia 52:98-107.
24. Noda M, Nakanishi H, Akaike N. 1999. Glutamate release from microglia via glutamate transporter is enhanced by amyloid-β peptide. Neuroscience 92:1465-1474.
25. 2y receptors. Brain Res 981:174-183.
26. 7 receptors in Müller glial cells from human retina. J Neurosci 20:5965-5972.
27. 7 mediates superoxide production in primary microglia and is up-regulated in a transgenic mouse model of Alzheimer's disease. J Biol Chem 278:13309-13317.
28. Persson M, Brantefjord M, Hansson E, Rönnbäck L. 2005. Lipopolysaccharide increases microglial GLT-1 expression and glutamate uptake capacity in vitro by a mechanism dependent on TNF-α. Glia 51:111-120.
29. Pines G, Danbolt NC, Bjoras M, Zhang Y, Bendahan A, Eide L, Koepsell H, Storm-Mathisen J, Seeberg E, Kanner BI. 1992. Cloning and expression of a rat brain L-glutamate transporter. Nature 360:464-467.
30. Pristupa ZB, McConkey F, Liu F, Man HY, Lee FJ, Wang YT, Niznik HB. 1998. Protein kinase-mediated bidirectional trafficking and functional regulation of the human dopamine transporter. Synapse 30:79-87.
31. Robinson MB, Dowd LA. 1997. Heterogeneity and functional properties of subtypes of sodium-dependent glutamate transporters in the mammalian central nervous system. Adv Pharmacol 37:69-115.
32. Rothstein JD, Martin LJ, Kuncl RW. 1992. Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis. N Engl J Med 326:1464-1468.
33. Sargsyan SA, Monk PN, Shaw PJ. 2005. Microglia as potential contributors to motor neuron injury in amyotrophic lateral sclerosis. Glia 51:241-253.
34. Shaked I, Tchoresh D, Gersner R, Meiri G, Mordechai S, Xiao X, Hart RP, Schwartz M. 2005. Protective autoimmunity: Interferon-γ enables microglia to remove glutamate without evoking inflammatory mediators. J Neurochem 92:997-1009.
35. Shibata T, Yamada K, Watanabe M, Ikenaka K, Wada K, Tanaka K, Inoue Y. 1997. Glutamate transporter GLAST is expressed in the radial glia-astrocyte lineage of developing mouse spinal cord. J Neurosci 17:9212-9219.
36. Springer JE, Azbill RD, Mark RJ, Begley JG, Waeg G, Mattson MP. 1997. 4-hydroxynonenal, a lipid peroxidation product, rapidly accumulates following traumatic spinal cord injury and inhibits glutamate uptake. J Neurochem 68:2469-2476.
37. +-dependent glutamate/aspartate transporter from rat brain. Proc Natl Acad Sci USA 89:10955-10959.
38. 7). Science 272:735-738.
39. Trotti D, Danbolt NC, Volterra A. 1998. Glutamate transporters are oxidant-vulnerable: A molecular link between oxidative and excitotoxic neurodegeneration ? Trends Pharmacol Sci 19:328-334.
40. 4 receptors induced in spinal microglia gate tactile allodynia after nerve injury. Nature 424:778-783.
41. 7-immunoreactivities are increased in activated microglial cells/macrophages of multiple sclerosis and amyotrophic lateral sclerosis spinal cord. BMC Neurol 6:12.
42. Zietlow R, Dunnett SB, Fawcett JW. 1999. The effect of microglia on embryonic dopaminergic neuronal survival in vitro: Diffusible signals from neurons and glia change microglia from neurotoxic to neuroprotective. Eur J Neurosci 11:1657-1667.